{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:10:24Z","timestamp":1726413024796},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00393-005-0014-3","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T05:46:57Z","timestamp":1137649617000},"page":"546-552","source":"Crossref","is-referenced-by-count":5,"title":["5-HT3-Rezeptor-Antagonisten als Analgetika bei rheumatischen Erkrankungen","5-HT3 receptor antagonists als analgetics in rheumatic diseases"],"prefix":"10.1007","volume":"65","author":[{"given":"W.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"Fiebich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(94)90331-X","volume":"170","author":"Arnalich","year":"1995","unstructured":"Arnalich F, de Miguel E, Perez-Ayala C, Martinez M, Vasquez JJ, Gijon-Banos J, Hernanz A (1995) Neuropeptides and interleukin-6 in human joint inflammation; relationship between intraarticular substance P and interleukin-6 concentration. Neurosci Lett 170:251\u2013254","journal-title":"Neurosci Lett"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bcp.2005.04.031","volume":"70","author":"de la Vega","year":"2005","unstructured":"de la Vega L, Munoz E, Calzado MA, Lieb K, Candelario-Jalil E, Haus U, M\u00fcller W, Stratz T, Fiebich BL (2005) The 5-HT3 receptor antagonist tropisetron inhibits T-cell activation by targeting the calcineurin pathway. Biochem Pharmakol 70:369\u2013380","journal-title":"Biochem Pharmakol"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/03009740410007041","volume":"33","author":"Ettlin","year":"2004","unstructured":"Ettlin T (2004) Trigger point injection treatment with the 5-HT3 receptor antagonist tropisetron in patients with late whiplash-associated disorder. First results of a multiple case study. Scand J Rheumatol 33(Suppl119):49\u201350","journal-title":"Scand J Rheumatol"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/03009740410006943","volume":"33","author":"F\u00e4rber","year":"2004","unstructured":"F\u00e4rber L, Haus U, Sp\u00e4th M, Drechsler S (2004) Physiology and pathophysiology of the 5-HT3 receptor. Scand J Rheumatol 33(Suppl 119):2\u20138","journal-title":"Scand J Rheumatol"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/030097400446643","volume":"29","author":"F\u00e4rber","year":"2000","unstructured":"F\u00e4rber L, Stratz T, Br\u00fcckle W, Sp\u00e4th M, Pongratz D, Lautenschl\u00e4ger J, K\u00f6tter I, Z\u00f6ller B, Peter HH, Neeck D, Alten R, M\u00fcller W (2000) Efficacy and tolerability of tropisetron in primary fibromyalgia \u2013 a highly selective and competitive 5-HT3 receptor antagonist. Scand J Rheumatol 29(Suppl 113):49\u201354","journal-title":"Scand J Rheumatol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/03009740410006998","volume":"33","author":"Fiebich","year":"2004","unstructured":"Fiebich BL, Akundi RS, Lieb K, Candelario-Jalil E, Gmeiner D, Haus U, M\u00fcller W, Stratz T, Munoz E (2004) Anti-inflammatory effects of 5-HT3-receptor antagonists in lipopolysaccharide-stimulated primary human monocytes. Scand J Rheumatol 33(Suppl 119):28\u201332","journal-title":"Scand J Rheumatol"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2165\/00003495-199753010-00003","volume":"55","author":"Greenshaw","year":"1997","unstructured":"Greenshaw AJ, Silverstone PH (1997) The non-anti-emetic uses of serotonin 5-HT3 receptor antagonists. Drug 55:20\u201339","journal-title":"Drug"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/030097400446652","volume":"29","author":"Haus","year":"2000","unstructured":"Haus U, Varga B, Stratz T, F\u00e4rber L, M\u00fcller W (2000) Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol 29(Suppl 113):55\u201358","journal-title":"Scand J Rheumatol"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(99)00101-0","volume":"99","author":"Khan","year":"1999","unstructured":"Khan NA, Poisson JP (1999) 5-HT3 receptor channels coupled with Na+ influx in human cells: role in T cell activation. J Neuroimmunol 99:53\u201360","journal-title":"J Neuroimmunol"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.6208609","volume":"226","author":"Levine","year":"1984","unstructured":"Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547\u2013549","journal-title":"Science"},{"key":"14_CR11","first-page":"11","volume":"49","author":"M\u00fcller","year":"1990","unstructured":"M\u00fcller W, Lautenschl\u00e4ger J (1990) Die generalisierte Tendomyopathie. Z Rheumatol 49:11\u201329","journal-title":"Z Rheumatol"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/03009740410007032","volume":"33","author":"M\u00fcller","year":"2004","unstructured":"M\u00fcller W, Stratz T (2004) Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol 33(Suppl 119):44\u201348","journal-title":"Scand J Rheumatol"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/316126a0","volume":"316","author":"Richardson","year":"1985","unstructured":"Richardson BP, Engel G, Donatsch P, Stadtler PA (1985) Idetification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126\u2013131","journal-title":"Nature"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/03009740410006970","volume":"33","author":"Riering","year":"2004","unstructured":"Riering K, Rewerts C, Zieglg\u00e4nsberger W (2004) Analgesic effects of 5-HT3 receptor antagonists. Scand J Rheumatol 33(Suppl 119):19\u201323","journal-title":"Scand J Rheumatol"},{"key":"14_CR15","unstructured":"Samborski W, Lacki JK, Urbaniak M, Mackiewicz S, M\u00fcller W (2000) Die Therapie der sekund\u00e4ren Fibromyalgie durch Blockierung der 5-HT3-Rezeptoren bei der chronischen Polyarthritis. Vortrag Rheuma-Symposium Bad S\u00e4ckingen 2000"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/03009740410007050","volume":"33","author":"Samborski","year":"2004","unstructured":"Samborski W, Stratz T, Mackiewicz S, M\u00fcller W (2004) Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol 33(Suppl 119):51\u201354","journal-title":"Scand J Rheumatol"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00001756-199010000-00005","volume":"1","author":"Saria","year":"1990","unstructured":"Saria A, Javorsky F, Humpel C, Gamse R (1990) 5-HT3-receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1:104\u2013106","journal-title":"Neuroreport"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s003930050224","volume":"2","author":"Schadrack","year":"1998","unstructured":"Schadrack J, Zieglg\u00e4nsberger W (1998) Pharmacology of pain processing systems. Z Rheumatol 2:1\u20134","journal-title":"Z Rheumatol"},{"key":"14_CR19","first-page":"normal","volume":"groups","author":"Shah","year":"2003","unstructured":"Shah JP, Phillips T, Danoff JV, Gerber LH (2003) A novel microanalytical technique for assaying soft tissue demonstrates significant quantitative biochemical differences in 3 clinically distinct groups: normal, latent and active. Arch Phys Med and Rehab 84, Nr 9","journal-title":"A novel microanalytical technique for assaying soft tissue demonstrates significant quantitative biochemical differences in 3 clinically distinct"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/03009740410005818","volume":"33","author":"Sp\u00e4th","year":"2004","unstructured":"Sp\u00e4th M, Stratz T, Neeck G, K\u00f6tter I, Hammel B, Amberger CC, Haus U, F\u00e4rber L, Pongratz D, M\u00fcller W (2004) Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol 33:267\u2013270","journal-title":"Scand J Rheumatol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/03009740410007023","volume":"33","author":"Stratz","year":"2004","unstructured":"Stratz T, Fiebich B, M\u00fcller W (2004) Influence of tropisetron on the serum substance P levels in fibromyalgia patients. Scand J Rheumatol 33(Suppl 119):41\u201343","journal-title":"Scand J Rheumatol"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/030097400446661","volume":"29","author":"Stratz","year":"2000","unstructured":"Stratz T, M\u00fcller W (2000) The use of 5-HT3 receptor antagonists in various rheumatic diseases \u2013 a clue to the mechanism of action in these agents in fibromyalgia? Scand J Rheumatol 29(Suppl 113):66\u201371","journal-title":"Scand J Rheumatol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/03009740410007113","volume":"33","author":"Stratz","year":"2004a","unstructured":"Stratz T, M\u00fcller W (2004a) Treatment of chronic low back pain with tropisetron. Scand J Rheumatol 33(Suppl 119):76\u201378","journal-title":"Scand J Rheumatol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/03009740410007078","volume":"33","author":"Stratz","year":"2004","unstructured":"Stratz T, M\u00fcller W (2004) Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron. Scand J Rheumatol 33(Suppl 119):59\u201362","journal-title":"Scand J Rheumatol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00393-003-0418-x","volume":"62","author":"Stratz","year":"2003","unstructured":"Stratz T, Varga B, M\u00fcller W (2003) Beeinflusst die Depressivit\u00e4t den Behandlungseffekt von Tropisetron bei Fibromyalgiepatienten? Z Rheumatol 62:42\u201345","journal-title":"Z Rheumatol"},{"key":"14_CR26","first-page":"225","volume":"53","author":"Stratz","year":"1994","unstructured":"Stratz T, Schochat T, Hrycaj P, Lacki J, Menet P, F\u00e4rber L, Schweiger C, M\u00fcller W (1994) Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren. Z Rheumatol 53:225\u2013338","journal-title":"Z Rheumatol"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1523\/JNEUROSCI.22-03-01010.2002","volume":"22","author":"Zeitz","year":"2002","unstructured":"Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WS, Sun L, Bonhaus DW, Stucky CL, Julius D (2002) The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 22:1010\u20131019","journal-title":"J Neurosci"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-005-0014-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-005-0014-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:33Z","timestamp":1559046573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-005-0014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s00393-005-0014-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}